Aberrant Transforming Growth Factor β1 Signaling and SMAD4 Nuclear Translocation Confer Epigenetic Repression of ADAM19 in Ovarian Cancer

Transforming growth factor-beta (TGF-β)/SMAD signaling is a key growth regulatory pathway often dysregulated in ovarian cancer and other malignancies. Although loss of TGF-β-mediated growth inhibition has been shown to contribute to aberrant cell behavior, the epigenetic consequence(s) of impaired T...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Chan, Michael WY, Huang, Yi-Wen, Hartman-Frey, Corinna, Kuo, Chieh-Ti, Deatherage, Daniel, Qin, Huaxia, Cheng, Alfred SL, Yan, Pearlly S, Davuluri, Ramana V, Huang, Tim H-M, Nephew, Kenneth P, Lin, Huey-Jen L
Format: Artigo
Jezik:Inglês
Izdano: Neoplasia Press Inc. 2008
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2517635/
https://ncbi.nlm.nih.gov/pubmed/18714391
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items